Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients
Clinical trial NCT00160992 · SUSPENDED
Trial details
- NCT number
- NCT00160992
- Sponsor
- University of Lausanne Hospitals
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.